|
Volumn 312, Issue 7, 2014, Pages 693-694
|
Avoiding nocebo effects to optimize treatment outcome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
REMIFENTANIL;
ADVERSE DRUG REACTION;
ANALGESIC ACTIVITY;
DOCTOR PATIENT RELATION;
DRUG EFFICACY;
DRUG INFORMATION;
DRUG TOLERABILITY;
FUNCTIONAL MAGNETIC RESONANCE IMAGING;
HEALTH CARE SYSTEM;
HUMAN;
INFORMED CONSENT;
LEGAL ASPECT;
MEDICAL EDUCATION;
MEDICAL PRACTICE;
NOCEBO EFFECT;
NOTE;
PATIENT COMPLIANCE;
PATIENT INFORMATION;
PLACEBO EFFECT;
PRIORITY JOURNAL;
PSYCHOLOGICAL ASPECT;
SYMPTOMATOLOGY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
CLINICAL TRIALS AS TOPIC;
COMMUNICATION;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
HUMANS;
NOCEBO EFFECT;
PATIENT EDUCATION AS TOPIC;
PHYSICIAN-PATIENT RELATIONS;
PLACEBO EFFECT;
|
EID: 84906535837
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.8342 Document Type: Note |
Times cited : (159)
|
References (9)
|